Rafael Chinchilla et al.
FULL PAPERS
Br): 370.1807; found: 370.1809; GLC (N-trifluoroacetamide es-
ter): Conditions A, tR (R) 38.57 min, (S) 39.65 min.
Isopropyl 3-(4-cyanophenyl)-2-(diphenylmethyleneami-
no)propanoate (7bj):[9b] 1H NMR: d¼1.21, 1.23 (6H, 2d, J¼
6.3 Hz), 3.24 (1H, dd, J¼13.3, 8.6 Hz), 3.31 (1H, dd, J¼13.3,
4.8 Hz), 4.20 (1H, dd, J¼8.6, 4.8 Hz), 5.04 (1H, hept, J¼
6.3 Hz), 6.70 (1H, d, J¼6.7 Hz), 7.18 (2H, d, J¼8.3 Hz),
7.26–7.62 (10H, m), 7.66 (1H, d, J¼8.4 Hz), 7.80 (1H, d, J¼
8.4 Hz); GLC (N-trifluoroacetamide ester): Conditions A, tR
(R) 53.43 min, tR (S) 54.20 min.
Isopropyl 3-(3-bromophenyl)-2-(diphenylmethyleneami-
no)propanoate (7bf): IR (film): n¼3063, 1731, 1660,
1
1107 cmÀ1; H NMR: d¼1.22, 1.24 (6H, 2d, J¼6.2 Hz), 3.14
(1H, dd, J¼13.3, 9.1 Hz), 3.22 (1H, dd, J¼13.3, 4.5 Hz), 4.17
(1H, dd, J¼9.1, 4.5 Hz), 5.05 (1H, hept, J¼6.2 Hz), 6.68 (1H,
d, J¼6.1 Hz), 7.02–7.57 (12H, m), 7.80 (1H, d, J¼7.9 Hz);
13C NMR: d¼21.8, 39.2, 66.9, 68.6, 122.1, 127.6, 128.0, 128.2,
128.4, 128.6, 128.7, 129.3, 129.6, 130.0, 130.3, 131.5, 132.4,
132.7, 136.1, 139.3, 140.5, 170.9, 171.0; MS: m/z¼449 (Mþ,
0.1), 364 (29), 362 (29), 281 (18), 280 (85), 238 (41), 194 (18),
193 (83), 180 (20), 179 (11), 166 (28), 165 (100), 102 (10), 77
(15); HRMS: calcd. for C21H17NBr (Mþ – CO2Pr-i): 362.0544;
found: 362.0540; GLC (N-trifluoroacetamide ester): Condi-
tions A, tR (R) 50.23 min, tR (S) 51.61 min.
Isopropyl
2-(diphenylmethyleneamino)-3-(4-methoxy-
phenyl)propanoate (7bk): IR (film): n¼3059, 3029, 1732,
1
1660, 1278, 1248 cmÀ1; H NMR: d¼1.21, 1.23 (6H, 2d, J¼
6.3 Hz), 3.11 (1H, dd, J¼13.5, 9.1 Hz), 3.21 (1H, dd, J¼13.5,
4.5 Hz), 3.75 (3H, s), 4.15 (1H, dd, J¼9.1, 4.5 Hz), 5.03 (1H,
hept, J¼6.3 Hz), 6.67 (1H, d, J¼6.9 Hz), 6.73 (2H, d, J¼
8.8 Hz), 6.97 (2H, d, J¼8.7 Hz), 7.25–7.37 (3H, m), 7.46 (2H,
m), 7.55 (2H, m), 7.79 (2H, m); 13C NMR: d¼21.8, 38.7, 55.2,
67.6, 68.3, 113.5, 127.6, 127.9, 128.1, 128.3, 128.4, 128.7, 130.0,
130.0, 130.7, 132.4, 136.4, 137.7, 139.5, 158.1, 170.5, 171.3; MS:
m/z¼401 (Mþ, 2), 314 (16), 281 (20), 280 (100), 238 (67), 194
(16), 193 (53), 192 (50), 166 (22), 165 (75), 121 (86), 91 (12),
77 (17); HRMS: calcd. for C26H27NO3: 401.1991; found:
401.1991; GLC (N-trifluoroacetamide ester): Conditions A,
tR (R) 37.34 min, tR (S) 38.28 min.
Isopropyl 3-(4-bromophenyl)-2-(diphenylmethyleneami-
no)propanoate (7bg): mp 97–98 8C; IR (KBr): n¼3065,
1
1731, 1623, 1110 cmÀ1; H NMR: d¼1.22, 1.24 (6H, 2d, J¼
6.1 Hz), 3.23 (1H, dd, J¼13.4, 9.8 Hz), 3.48 (1H, dd, J¼13.4,
4.0 Hz), 4.14 (1H, dd, J¼9.8, 4.0 Hz), 5.04 (1H, hept, J¼
6.1 Hz), 6.60 (1H, d, J¼6.1 Hz), 7.01–7.59 (12H, m), 7.81
(1H, d, J¼7.9 Hz); 13C NMR d¼21.8, 39.5, 64.6, 68.5, 125.2,
126.9, 127.6, 127.9, 128.0, 128.1, 128.24, 128.3, 128.8, 130.0,
130.2, 132.4, 132.5, 132.7, 133.3, 136.0, 137.3, 139.3, 171.0; MS:
m/z¼406 (Mþ – i-Pr, 0.05), 364 (17), 363 (18), 281 (18), 280
(92), 238 (50), 194 (18), 193 (78), 192 (40), 166 (29), 165
Isopropyl 2-(diphenylmethyleneamino)-3-(naphthalen-2-
yl)propanoate (7bl):[9b] 1H NMR: d¼1.21, 1.23 (6H, 2d, J¼
6.3 Hz), 3.33 (1H, dd, J¼13.3, 9.2 Hz), 3.47 (1H, dd, J¼13.3,
4.4 Hz), 4.31 (1H, dd, J¼9.2, 4.4 Hz), 5.04 (1H, hept, J¼
6.3 Hz), 6.54 (2H, d, J¼7.0 Hz), 7.14–7.81 (15H, m); GLC
(N-trifluoroacetamide ester): Conditions A, tR (R) 50.31 min,
tR (S) 51.08 min.
(100), 90 (10), 77 (16); HRMS: calcd. for C21H17NBr (Mþ
–
CO2Pr-i): 362.0544; found: 362.0593; GLC (N-trifluoroacet-
amide ester): Conditions A, tR (R) 41.11 min, tR (S) 42.10 min.
Isopropyl
2-(diphenylmethyleneamino)pent-4-enoate
(7bm): IR (film): n¼3063, 1747, 1660 cmÀ1; H NMR: d¼
1.22, 1.24 (6H, d, J¼6.2 Hz), 2.58–2.74 (2H, m), 4.08 (2H,
dd, J¼7.6, 5.5 Hz), 4.99–5.10 (3H, m), 5.64–5.78 (1H, m),
7.17 (1H, m), 7.29–7.50 (6H, m), 7.60 (2H, m); 13C NMR: d¼
21.7, 38.1, 65.3, 68.2, 117.4, 127.8, 127.9, 128.2, 128.4, 128.5,
128.8, 130.0, 130.2, 132.4, 134.4, 136.5, 137.5, 139.6, 170.4,
171.2; MS: m/z¼321 (Mþ, 22), 280 (51), 238 (51), 235 (21),
234 (96), 194 (15), 193 (50), 192 (67), 166 (25), 165 (100), 131
(25), 129 (15), 116 (12), 104 (13), 91 (27), 77 (13); HRMS: calcd.
for C21H23NO2: 321.1729; found: 321.1755; GLC (N-trifluoro-
acetamide ester): Conditions B, tR (R) 7.50 min, tR (S) 8.54 min.
1
Isopropyl
2-(diphenylmethyleneamino)-3-(4-iodophe-
nyl)propanoate (7bh): mp 106–107 8C; IR (KBr); n¼3068,
1
3022, 1742, 1624 cmÀ1; H NMR: d¼1.21, 1.23 (6H, 2d, J¼
6.3 Hz), 3.10 (1H, dd, J¼13.4, 8.9 Hz) 3.18 (1H, dd, J¼13.4,
4.3 Hz), 4.15 (1H, dd, J¼8.9, 4.3 Hz), 5.03 (1H, hept, J¼
6.3 Hz), 6.67 (1H, d, J¼6.3 Hz), 6.80 (1H, d, J¼7.9 Hz),
7.09–7.40 (6H, m), 7.45–7.59 (4H, m), 7.66 (1H, d, J¼
7.9 Hz), 7.80 (1H, d, J¼7.9 Hz); 13C NMR: d¼21.7, 39.0,
67.0, 68.5, 91.4, 125.2, 127.5, 128.0, 128.2, 128.2, 128.4, 128.7,
129.0, 130.0, 130.3, 130.8, 131.9, 132.4, 136.0, 137.1, 137.8,
137.9, 139.2, 170.8, 170.9; MS: m/z¼410 (Mþ – CO2Pr-i, 25),
281 (20), 280 (100), 238 (46), 194 (17), 193 (71), 192 (37), 180
(14), 179 (12), 166 (26), 165 (88), 90 (14), 77 (14); HRMS: calcd.
for C21H17NI (Mþ– CO2Pr-i): 410.0406; found: 410.0370; GLC
(N-trifluoroacetamide ester): Conditions A, tR (R) 45.19 min,
tR (S) 46.09 min.
Isopropyl
2-(diphenylmethyleneamino)pent-4-ynoate
(7bn): IR (film): n¼3296, 3065, 3031, 1734, 1623 cmÀ1
;
1H NMR: d¼1.21, 1.23 (6H, 2d, J¼6.2 Hz), 2.72–2.88 (3H,
m), 4.24 (1H, dd, J¼7.5, 6.5 Hz), 5.05 (1H, hept, J¼6.2 Hz),
7.25–7.56 (5H, m), 7.59 (1H, d, J¼7.2 Hz), 7.65 (2H, d, J¼
7.3 Hz), 7.80 (2H, d, J¼7.5 Hz); 13C NMR: d¼21.7, 23.3,
64.2, 68.8, 70.1, 81.0, 128.0, 128.2, 128.4, 128.6, 128.9, 130.0,
130.4, 132.4, 136.1, 137.6, 139.9, 169.9, 171.7; MS: m/z¼319
(Mþ, 18), 318 (70), 280 (26), 276 (15), 238 (29), 233 (16), 232
(82), 205 (12), 194 (13), 193 (49), 192 (77), 166 (23), 165
(100), 129 (19), 128 (37), 127 (24), 77 (14); HRMS: calcd. for
C21H21NO2: 319.1572; found: 319.1571; GLC (N-trifluoroacet-
amide ester): Conditions B, tR (R) 7.84 min, tr (S) 8.26 min.
Isopropyl
2-(diphenylmethyleneamino)-3-(4-nitrophe-
nyl)propanoate (7bi): mp 140–141 8C; IR (KBr): n¼3083,
1732, 1628 cmÀ1; 1H NMR: d¼1.22, 1.24 (6H, 2d, J¼6.2 Hz),
3.29 (1H, dd, J¼13.3, 8.5 Hz), 3.34 (1H, dd, J¼13.3, 4.9 Hz),
4.24 (1H, dd, J¼8.5, 4.9 Hz), 5.05 (1H, hept, J¼6.2 Hz), 6.71
(1H, d, J¼6.9 Hz), 7.23–7.39 (4H, m), 7.46–7.62 (4H, m),
7.81 (2H, m), 8.06 (1H, m), 8.26 (2H, m); 13C NMR: d¼21.8,
39.4, 66.5, 68.9, 126.4, 127.5, 127.5, 128.1, 128.3, 128.7, 130.0,
130.6, 130.7, 132.4, 135.9, 137.6, 139.0, 146.2, 170.5, 171.3; MS:
m/z¼329 (Mþ – CO2Pr-i, 63), 281 (11), 280 (53), 238 (32),
194 (15), 193 (66), 192 (37), 180 (17), 179 (17), 178 (12), 166
(26), 165 (100), 104 (12), 77 (18); HRMS: calcd. for
C21H17N2O2 (Mþ – CO2Pr-i): 329.1290; found: 329.1290; GLC
(N-trifluoroacetamide ester): Conditions A, tR (R) 53.02 min,
tR (S) 54.07 min.
Preparation of SynPhaseTM Lantern-Supported
Ammonium Salts 9 and 10
To a suspension of cinchonidine or cinchonine (0.5 mmol,
148 mg) in CH2Cl2 (8 mL) wasadded A-Serieschloromethylat-
1192
ꢁ 2004 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
asc.wiley-vch.de
Adv. Synth. Catal. 2004, 346, 1186–1194